Sleepcheck will get licensed out .Their was a German clinical paper seems to me paid by Resmed??
that compared 3 apps x 3 levels ( low,mid,high). Product A lost out on all 3, Resmed and Resapp similar in mid level but they didn’t show number for high level except in the conclusion which said something like
Resapp sleepcheck it would appear at high level to be better blah blah.
So I see this as a product for one of the big guys who will use it in their system pay us a flat fee plus bonus as each customer is a long term ( rest of their lives ) client.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report and Appendix 4C
Sleepcheck will get licensed out .Their was a German clinical...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online